DRIO — DarioHealth Cashflow Statement
0.000.00%
Last trade - 00:00- $34.15m
- $25.61m
- $20.35m
- 20
- 54
- 27
- 25
Annual cashflow statement for DarioHealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.7 | -29.4 | -76.8 | -62.2 | -59.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.63 | 11.4 | 26.3 | 20.1 | 20.2 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.797 | 0.15 | -3.29 | -10.5 | 3.83 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -15.7 | -17.7 | -50.4 | -47.8 | -30.4 |
| Capital Expenditures | -0.098 | -0.118 | -0.261 | -0.573 | -0.584 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.015 | -1.5 | -7.87 | 0 | 0.037 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.113 | -1.62 | -8.13 | -0.573 | -0.547 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 25.2 | 27.5 | 65.8 | 61.9 | 18.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.41 | 8.19 | 7.22 | 13.5 | -12.7 |